SG11201810725WA - Novel β-lactamase inhibitors - Google Patents
Novel β-lactamase inhibitorsInfo
- Publication number
- SG11201810725WA SG11201810725WA SG11201810725WA SG11201810725WA SG11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA
- Authority
- SG
- Singapore
- Prior art keywords
- lactamase inhibitors
- novel
- disclosed
- lactamase
- novelb
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610394846 | 2016-06-03 | ||
| PCT/CN2017/086999 WO2017206947A1 (zh) | 2016-06-03 | 2017-06-02 | 新型β-内酰胺酶抑制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810725WA true SG11201810725WA (en) | 2018-12-28 |
Family
ID=60477996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810725WA SG11201810725WA (en) | 2016-06-03 | 2017-06-02 | Novel β-lactamase inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10738051B2 (ja) |
| EP (1) | EP3466950B1 (ja) |
| JP (1) | JP6929881B2 (ja) |
| KR (1) | KR102392350B1 (ja) |
| CN (1) | CN109311881B (ja) |
| AU (1) | AU2017274131B2 (ja) |
| CA (1) | CA3026322C (ja) |
| ES (1) | ES2863725T3 (ja) |
| MY (1) | MY193239A (ja) |
| RU (1) | RU2741963C2 (ja) |
| SG (1) | SG11201810725WA (ja) |
| WO (1) | WO2017206947A1 (ja) |
| ZA (1) | ZA201808552B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2928152T3 (es) * | 2017-12-01 | 2022-11-15 | Qilu Pharmaceutical Co Ltd | Forma cristalina de un inhibidor de beta-lactamasa y método de preparación de la misma |
| CN111511737B (zh) * | 2018-01-29 | 2022-10-18 | 南京明德新药研发有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
| JP7249438B2 (ja) * | 2019-05-30 | 2023-03-30 | 卓和薬業集団股▲ふん▼有限公司 | 抗菌性アミノグリコシド誘導体 |
| US20230022708A1 (en) * | 2019-12-19 | 2023-01-26 | Medshine Discovery Inc. | Application of compound in drug preparation |
| CN113292499B (zh) * | 2020-02-24 | 2024-05-28 | 齐鲁制药有限公司 | 一种β-内酰胺酶抑制剂的新制备方法及其中间体 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100463403C (zh) * | 2006-03-20 | 2009-02-18 | 腾讯科技（深圳）有限公司 | 一种基于点对点技术的图片共享系统和方法 |
| JP4809097B2 (ja) * | 2006-03-29 | 2011-11-02 | ルネサスエレクトロニクス株式会社 | 受信回路及び受信方法 |
| JP6023800B2 (ja) | 2011-06-17 | 2016-11-09 | アストラゼネカ アクチボラグ | ｔｒａｎｓ−７−オキソ−６−（スルホオキシ）−１，６−ジアザビシクロ［３，２，１］オクタン−２−カルボキサミドとその塩が含まれる複素環式化合物を製造するための方法 |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| US9505761B2 (en) * | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| JP2015512419A (ja) * | 2012-03-30 | 2015-04-27 | キュービスト ファーマシューティカルズ， インコーポレイテッド | イソオキザゾールβ−ラクタマーゼ阻害剤 |
| TWI565707B (zh) | 2012-05-30 | 2017-01-11 | 明治製菓藥業股份有限公司 | 新穎β－內醯胺酶抑制劑及其製造方法 |
| ES2672100T3 (es) * | 2012-08-25 | 2018-06-12 | Wockhardt Limited | Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona y su uso en el tratamiento de infecciones bacterianas |
| UA111925C2 (uk) * | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
-
2017
- 2017-06-02 SG SG11201810725WA patent/SG11201810725WA/en unknown
- 2017-06-02 WO PCT/CN2017/086999 patent/WO2017206947A1/zh unknown
- 2017-06-02 AU AU2017274131A patent/AU2017274131B2/en active Active
- 2017-06-02 MY MYPI2018002269A patent/MY193239A/en unknown
- 2017-06-02 EP EP17805892.1A patent/EP3466950B1/en active Active
- 2017-06-02 JP JP2018562934A patent/JP6929881B2/ja active Active
- 2017-06-02 CA CA3026322A patent/CA3026322C/en active Active
- 2017-06-02 KR KR1020187037429A patent/KR102392350B1/ko active IP Right Grant
- 2017-06-02 US US16/305,414 patent/US10738051B2/en active Active
- 2017-06-02 RU RU2018146128A patent/RU2741963C2/ru active
- 2017-06-02 CN CN201780034023.6A patent/CN109311881B/zh active Active
- 2017-06-02 ES ES17805892T patent/ES2863725T3/es active Active
-
2018
- 2018-12-19 ZA ZA2018/08552A patent/ZA201808552B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2741963C2 (ru) | 2021-02-01 |
| ZA201808552B (en) | 2022-11-30 |
| US20200010467A1 (en) | 2020-01-09 |
| EP3466950A1 (en) | 2019-04-10 |
| WO2017206947A1 (zh) | 2017-12-07 |
| JP6929881B2 (ja) | 2021-09-01 |
| AU2017274131A1 (en) | 2019-01-24 |
| RU2018146128A (ru) | 2020-07-10 |
| JP2019517501A (ja) | 2019-06-24 |
| KR102392350B1 (ko) | 2022-04-29 |
| EP3466950A4 (en) | 2019-11-20 |
| US10738051B2 (en) | 2020-08-11 |
| ES2863725T3 (es) | 2021-10-11 |
| AU2017274131B2 (en) | 2020-10-08 |
| RU2018146128A3 (ja) | 2020-07-10 |
| CA3026322C (en) | 2023-08-15 |
| KR20190015350A (ko) | 2019-02-13 |
| EP3466950B1 (en) | 2021-02-24 |
| CN109311881A (zh) | 2019-02-05 |
| CN109311881B (zh) | 2021-07-13 |
| MY193239A (en) | 2022-09-27 |
| CA3026322A1 (en) | 2017-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810725WA (en) | Novel β-lactamase inhibitors | |
| MX2018010192A (es) | Inhibidores de glucosidasa. | |
| GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
| PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
| MX2022006783A (es) | Nuevos derivados de metilquinazolinona. | |
| MY196186A (en) | Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor | |
| MX2022014864A (es) | Compuestos de bisamida que activan el sarcomero y sus usos. | |
| SA520412335B1 (ar) | مشتقات أوكسي فلورو ببريدين كمثبط كيناز | |
| MX2020009234A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos. | |
| MX2020006613A (es) | Derivados de aril-bipiridina amina como inhibidores de fosfatidilinositol fosfato cinasa. | |
| AU2018253590A1 (en) | Imidazopyridazine compounds | |
| MX2022016515A (es) | Nuevo inhibidor de la secrecion de acido y uso del mismo. | |
| PH12019500839A1 (en) | Therapeutic compounds and methods of use thereof | |
| MX2015017156A (es) | Inhibidores de bace. | |
| MX2017005422A (es) | Inhibidores de histona desacetilasa y sus usos en terapia. | |
| MX2021015514A (es) | Compuesto heterociclico. | |
| PH12019500875A1 (en) | Pyridone compound as c-met inhibitor | |
| MX2019006768A (es) | Peptidos antimicrobianos. | |
| TN2021000025A1 (en) | Novel heterocyclic amine derivative and pharmaceutical composition comprising same | |
| MX2018008966A (es) | Procesos mejorados para la preparacion de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo. | |
| SG11201907945YA (en) | Azetidine derivative | |
| MX2021009261A (es) | Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1. | |
| TN2019000038A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| PH12019502046A1 (en) | Pyrrolotriazine derivatives as kinase inhibitor | |
| MX2019015747A (es) | Compuesto heterociclico. |